Announcement

Collapse
No announcement yet.

Review of genetics

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
    Graham
    Forum Member

  • Graham
    replied
    Thank you Andy, much appreciated.

    The fact that the Brainstorm share price fell by 67 percent today sums up the reality that the Brainstorm trial failed. Very sad and disappointing. However, BCLI's net capitalisation despite the drop is $125M, more than twice in 2014, so the company will carry on.

    There are more phase 3 trials Andy but I'm not sure what they are. I think the antisense trials offer hope too.

    Leave a comment:

  • Ellie
    Forum Member

  • Ellie
    replied
    Following on from Barry's post:

    I listened into the Brainstorm press conference re NurOwn's Phase III results, quite interesting. A recording is available for a short period of time https://www.webcaster4.com/Webcast/Page/2354/38723

    If you need a passcode, it's 38723

    I see their share price dived...

    Leave a comment:

  • Barry52
    Forum Member

  • Barry52
    replied
    Originally posted by nunhead_man View Post
    Good morning Graham,

    As far as I know, there is nothing in phase 3.

    The one I'm vaguely keeping my eye on is Nurown (sorry I'm not sure that's the right spelling) which is some sort of nostrum that is injected into the spine and has caused a number of people in the US phase 3 trial to reverse symptoms and that reversal has now reversed back given the trial has ended while the drug company tries to get some money to invest in producing the thing.

    Of course, the US is a bit of a minefield at the moment given the vast amount of money being ploughed into Covid treatments and seemingly taking money away, at least investment money, from things that deal with stuff like MND
    Hi Andy,

    posted today https://ir.brainstorm-cell.com/2020-...se-3-ALS-Study

    Leave a comment:

  • nunhead_man
    Forum Member

  • nunhead_man
    replied
    Good morning Graham,

    As far as I know, there is nothing in phase 3.

    The one I'm vaguely keeping my eye on is Nurown (sorry I'm not sure that's the right spelling) which is some sort of nostrum that is injected into the spine and has caused a number of people in the US phase 3 trial to reverse symptoms and that reversal has now reversed back given the trial has ended while the drug company tries to get some money to invest in producing the thing.

    Of course, the US is a bit of a minefield at the moment given the vast amount of money being ploughed into Covid treatments and seemingly taking money away, at least investment money, from things that deal with stuff like MND

    Leave a comment:

  • denise
    Forum Member

  • denise
    replied
    Received some really good news today. Stephens als is not genetic. Thank goodness.

    Leave a comment:

  • Graham
    Forum Member

  • Graham
    replied
    Andy,

    Which is the MNDA's preferred treatment currently in Phase 3?

    Leave a comment:

  • jd58
    Forum Member

  • jd58
    replied
    Thnkyou for posting Andy

    Leave a comment:

  • denise
    Forum Member

  • denise
    replied
    Yes thanks andy

    Leave a comment:

  • Doug Carpenter
    Forum Member

  • Doug Carpenter
    replied
    Thanks for passing this on Andy.

    Doug

    Leave a comment:

  • nunhead_man
    Forum Member

  • nunhead_man
    started a topic Review of genetics

    Review of genetics

    This is a master of reviewers reviewing the genetic position.....

    With thanks to Lee Millard on Twitter pointing this out

    https://www.sciencedirect.com/scienc...69996120304319
Working...
X